Expand AGE Menu

AGE Stock Summary and Trading Ideas (Agex Therapeutics | AMEX:AGE)

Agex Therapeutics (AGE) Frequently Asked Questions

What does Agex Therapeutics do?

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

What symbol and exchange does Agex Therapeutics stock trade?

Agex Therapeutics trades on the AMEX stock market under the symbol AGE.

What is Agex Therapeutics stock price doing today?

As of September 29, 2023, AGE stock price was flat at $0.68 with 6,443 million shares trading.

What is Agex Therapeutics's Beta?

AGE has a beta of 0.63, meaning it tends to be less sensitive to market movements. AGE has a correlation of 0.02 to the broad based SPY ETF.

How much is Agex Therapeutics worth?

AGE has a market cap of $25.80 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Agex Therapeutics traded in the last 3 year period?

In the last 3 years, AGE stock traded as high as $3.93 and as low as $.37.

What are the top ETFs holding Agex Therapeutics?

The top ETF exchange traded funds that AGE belongs to (by Net Assets): VTI, VXF, ITOT.

Is Agex Therapeutics (AGE) a good investment?

AGE has outperformed the market in the last year with a return of +17.2%, while the SPY ETF gained +17.1%. However, in the most recent history, AGE shares have underperformed the stock market with its stock returning -22.1% in the last 3 month period and -13.8% for the last 2 week period, while SPY has returned -1.7% and -4.4%, respectively.

What is the support and resistance for Agex Therapeutics (AGE) stock price?

AGE support price is $.63 and resistance is $.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGE stock will trade within this expected range on the day.